Business News | ABILITY DIABETES GLOBAL - A Landmark RCT in the Field of PCI for Patients with DM, Completes Enrolment

Get latest articles and stories on Business at LatestLY. ABILITY DIABETES-GLOBAL (ADG), is the World's largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing head-to-head the Sirolimus eluting stent, Abluminus DES+ (Concept Medical Inc.) with the XIENCE family of DES (Abbott Cardiovascular). Business News | ABILITY DIABETES GLOBAL - A Landmark RCT in the Field of PCI for Patients with DM, Completes Enrolment.

Related Keywords

Florida ,United States ,Bangladesh ,India ,Tampa ,Netherlands ,Singapore ,Brazil ,Instituto Dante Pazzanese ,Daniel Chamie ,Maarten Vink ,Fazila Malik ,Roxana Mehran ,Alexandre Abizaid ,School Of Medicine ,Concept Medical Inc ,Research Centre Bangladesh ,Cardiovascular European Research Center ,National Heart Foundation Hospital ,Randomized Controlled Trial ,Diabetes Mellitus ,Abbott Cardiovascular ,Marie Claude Morice ,Medical Director ,Antonio Colombo ,Shigeru Saito ,Principal Investigators ,Mount Sinai ,Dante Pazzanese De Cardiologia ,Research Centre ,Concept Medical ,